Selectins with a catch ot content simply with a good fit, evolution has apparently designed adhesion molecules that stick optimally only when tugged upon. This property, say Bryan
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But at the nanoscale mineral sizes found in virtually all biocomposites, the story is different. "At nanoscale the volume is too small, so the strain energy stored in the mineral is too small to break the bond," says Gao. "So the crack will not grow-these flaws will not matter."
Gao says that this principle explains a case of convergent evolution: the similarly small sizes of mineral particles in a wide range of biocomposites. Nanoscale sizing can also be used in making artificial materials. Material processing, he says, "is often like cooking," with lots of experimenting with ingredients backed up by little theory. So a principle from biology is welcome. He and his colleagues have used the nanoscale theory to study a composite coating-made of As mineral size decreases (left to right) to reach that found in tooth enamel (inset), the fracture resistance increases. Leoben, Leoben, Austria) , and colleagues find that the small size of the mineral particles in bone, teeth, and nacre (mother-of-pearl) is the key to their strength, and that the same principle can be applied to the construction of artificial materials.
Bones, teeth, and nacre are all biocomposites. A protein matrix absorbs and distributes shocks, but its softness is buttressed by hard, embedded minerals. Somehow the resulting combination is a material that can be thousands of times less susceptible to fracture than the pure mineral.
Fracture of the pure mineral initiates at flaws. "It's inevi-S table that a mineral will be flawed," says Gao. "No material is pure. Just from entropic effects you will have impurities." This is especially true in biocomposites, where proteins will sneak into and disrupt a mineral matrix. Gao calculated how the fracture strength of such a flawed mineral would vary with changing crystal thickness. After an insult, the amount of energy absorbed by a given crystal depends on the crystal's volume. Much of that energy will be concentrated at the most serious flaw, perhaps leading to its rupture and thus a catastrophic failure.
roll along vessel walls when their PSGL-1 binds to the P-selectin found on activated endothelial cells.
At high shear forces, increasing shear leads to decreasing binding lifetime. But the Georgia Tech group found that this "slip" mode was reversed at lower shear forces. In this "catch" mode, found only below a certain limit of shear force, binding lifetime At low forces, adhesion lifetimes increase with increasing force.
Zhu/Macmillan increased with increasing shear force. For the individual binding events measured, the catch mode shear forces were small-as small as those produced by a few molecular motors. But Zhu feels that the catch mode is relevant in the real world, where the larger shear forces are distributed across many binding events per cell.
The crystal structure of the binding complex does not point to an obvious catch mechanism, although molecular dynamics simulations may yield clues. Zhu is also interested in exploring the binding energy landscapes. Any bound state is a kinetic trap, so perhaps the force both raises the bottom of this energy well and, even more, elevates the energy barrier blocking escape. Or force might make a short lifetime exit path inaccessible. Whatever the mechanism, the product is a cell that inspects closely only when it has a moving target. Reference: Marshall, B.T., et al. 2003. Nature. 423:190-193 . 
Calcium goes nuclear
fine reticulum that pokes its fingers across the nucleus is capable of storing and releasing calcium, according to Wihelma Echevarría, Michael Nathanson (Yale University, New Haven, CT), and colleagues. The physiological activators of the compartment remain obscure, but they could potentially induce localized signaling in the nucleus.
Intranuclear extensions of the ER have been described previously, but the Yale group is the first to show that the compartment both contains and can release calcium. Localized photorelease of inositol 1,4,5-trisphosphate (InsP 3 ) in the nucleus resulted in a gradient of calcium A Nuclear calcium transients send PKC to the nuclear envelope (top right) rather than the plasma membrane (bottom right).
Nathanson/Macmillan
that spread from the site of photorelease across the nucleus. The effects of nuclear calcium release were distinct from those of cytosolic calcium release: nuclear calcium caused translocation of a labeled protein kinase C (PKC) to the nuclear envelope, whereas cytosolic calcium triggered PKC translocation to the plasma membrane.
Several growth factor receptors are known to translocate to and signal in the nucleus. And several transcription factors-targets of signal transduction pathwaysrely on calcium as one of their stimulatory inputs. As yet there is no obvious candidate pathway that combines both of these characteristics. But, if such a pathway is identified, two important factors-the site of calcium release and the proximity of target genes to this site-may help control the strength of the pathway's output. Reference: Echevarría, W., et al. 2003. Nat. Cell Biol. 5:440-446. A graveyard for mRNA nother day, another organelle. Cytoplasmic foci of various mRNA processing enzymes have now been confirmed by Ujwal Sheth and Roy Parker (University of Arizona, Tucson, AZ) as functional sites for degrading mRNA. But that confirmation has led to a host of questions about the origins and range of functions of these processing bodies (P bodies).
Sheth and Parker found that mRNA decapping enzymes, activators of decapping, and an mRNA nuclease all clustered in two to three P bodies per budding yeast cell. The P bodies melted away when mRNA turnover was inhibited before decapping (by inhibiting deadenylation), but proliferated when the inhibition was at or after the decapping step. Finally, a decay intermediate was localized to P bodies.
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The range of reactions occurring in the P bodies remains to be explored, as does the significance of the structure. "Whether the [degradation] biochemistry requires the macroscopic environment [of the P body] or can occur in a dispersed fashion is not known," says Parker.
A full understanding of P body control is also hampered by the field's poor grip on what controls the switches between different mRNA states: from active translation to storage or destruction. At least one factor implicated in storage is found in the P bodies, so these bodies may do double duty in storage and destruction. At the very least, says Parker, the P bodies sequester mRNAs that are being degraded, so they do not compete for factors with mRNAs that are being actively translated. Determining how much additional regulation is present is work for the future. The response appears to be part of a normal program used to create and maintain organs-a process that uses oxygen gradients as one guiding principle. "Mother Nature has given us the invasion program not to promote metastasis but to promote sprouting and branching of epithelial tubes," says Comoglio.
In hypoxic tumor cells, his team found that binding of hypoxia inducible factor-1 (HIF-1) to two sites in the met promoter-induced expression of the Met tyrosine kinase receptor. This newly abundant Met, after the binding of ubiquitous hepatocyte growth factor (HGF, or scatter factor-1), activates an invasive migration program.
They found that Met levels were dramatically increased in the hypoxic areas of tumors, and that high levels of Met were both necessary for hypoxiainduced branching morphogenesis and sufficient to induce branching morphogenesis in normoxic conditions.
Previous workers have stressed that hypoxia induces angiogenesis and apoptosis resistance. But the new work suggests that treatment with antiangiogenic agents is too simplistic. These drugs increase hypoxia in a tumor, and may thus promote metastasis. A combination therapy that attacks both angiogenic and metastatic pathways may have a better chance of success. Reference: Pennacchietti, S., et al. 2003. Cancer Cell. 3:347-361 .
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The proinvasive effect of HGF (left) is amplified by hypoxia (right).
